David Linetsky Sells 720 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP David Linetsky sold 720 shares of the stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $29.50, for a total value of $21,240.00. Following the sale, the senior vice president now directly owns 230,051 shares in the company, valued at approximately $6,786,504.50. The trade was a 0.31 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

David Linetsky also recently made the following trade(s):

• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The stock was sold at an average price of $29.52, for a total value of $8,856.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The stock was sold at an average price of $29.68, for a total value of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total value of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The stock was sold at an average price of $24.85, for a total value of $294,547.05.

Phreesia Stock Down 1.8 %

Shares of NYSE:PHR traded down $0.53 during mid-day trading on Tuesday, hitting $28.45. 189,355 shares of the company traded hands, compared to its average volume of 361,587. The firm has a market cap of $1.65 billion, a P/E ratio of -19.35 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.90. The firm's 50 day simple moving average is $26.13 and its 200 day simple moving average is $23.53.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period in the previous year, the business earned ($0.58) EPS. Phreesia's revenue for the quarter was up 16.6% compared to the same quarter last year. On average, equities analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. R Squared Ltd acquired a new position in shares of Phreesia in the 4th quarter worth approximately $30,000. BankPlus Trust Department acquired a new position in shares of Phreesia in the 4th quarter worth approximately $34,000. International Assets Investment Management LLC grew its position in shares of Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after acquiring an additional 1,395 shares in the last quarter. Venturi Wealth Management LLC acquired a new position in shares of Phreesia in the 4th quarter worth approximately $76,000. Finally, Smartleaf Asset Management LLC boosted its position in Phreesia by 154.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after purchasing an additional 2,090 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on PHR. JMP Securities reissued a "market outperform" rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Robert W. Baird cut their price objective on Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a report on Wednesday, December 11th. Needham & Company LLC restated a "buy" rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. Truist Financial raised their price objective on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Finally, Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and raised their price objective for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has a consensus rating of "Buy" and a consensus price target of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.